These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4085300)

  • 1. [Effect of silica shield intrauterine devices on menstrual blood loss and iron balance].
    Wu SC; Gao J
    Zhonghua Fu Chan Ke Za Zhi; 1985 Sep; 20(5):306-8, 320. PubMed ID: 4085300
    [No Abstract]   [Full Text] [Related]  

  • 2. Menstrual bleeding pattern and iron status in women fitted with copper and non-medicated intrauterine contraceptive devices.
    Oyelola OO; Okonofua FE; Adediran TO
    East Afr Med J; 1994 Apr; 71(4):268-70. PubMed ID: 8062778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment by tranexamic acid in menorrhagia in women using intrauterine devices].
    Bengtsson LP; Weström L
    Lakartidningen; 1971 Aug; 68(33):3685-91. PubMed ID: 5129410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anemia and menstrual blood loss.
    Cohen BJ; Gibor Y
    Obstet Gynecol Surv; 1980 Oct; 35(10):597-618. PubMed ID: 6997784
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of prostaglandins in IUD-associated uterine bleeding--effect of a prostaglandin synthetase inhibitor (ibuprofen).
    Roy S; Shaw ST
    Obstet Gynecol; 1981 Jul; 58(1):101-6. PubMed ID: 7243136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in menstrual bleeding caused by the use of the IUD].
    Pedrón Nuevo N
    Arch Invest Med (Mex); 1988; 19(3):245-52. PubMed ID: 3242436
    [No Abstract]   [Full Text] [Related]  

  • 7. Menstrual blood-loss with intrauterine devices.
    Guillebaud J; Bonnar J; Morehead J; Matthews A
    Lancet; 1976 Feb; 1(7956):387-90. PubMed ID: 55650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study and significance of ferritin levels in 104 women using intrauterine devices].
    Faguer C
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(2):141-4. PubMed ID: 8040570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind trial of ethamsylate in the treatment of primary and intrauterine-device menorrhagia.
    Harrison RF; Cambell S
    Lancet; 1976 Aug; 2(7980):283-5. PubMed ID: 59855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The morphologic changes of endometrial hematostatic reaction in intrauterine devices induced menorrhagia].
    Pan J; Yu Y; Chen G
    Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):526-9. PubMed ID: 8556910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypermenorhagia in intrauterine anticonception and pelvic inflammations (author's transl)].
    Pĕtros J; Nesit V
    Cesk Gynekol; 1981 Dec; 46(10):760-2. PubMed ID: 7332944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifibrinolytic control of menorrhagia after I.U.D. insertion.
    MacMath IF
    Practitioner; 1973 Mar; 210(257):417-20. PubMed ID: 4571360
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of ethamsylate and aminocaproic acid on menstrual blood loss in women using intrauterine devices.
    Kasonde JM; Bonnar J
    Br Med J; 1975 Oct; 4(5987):21-2. PubMed ID: 1174906
    [No Abstract]   [Full Text] [Related]  

  • 15. Pain and heavy bleeding with intrauterine contraceptive devices.
    Rose SB
    BMJ; 2007 Sep; 335(7617):410-1. PubMed ID: 17762004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcified bodies and the intrauterine device.
    Highman WJ
    Acta Cytol; 1971; 15(5):473-5. PubMed ID: 4329490
    [No Abstract]   [Full Text] [Related]  

  • 17. Vitamin E (alpha tocopherol) in the management of menorrhagia associated with the use of intrauterine contraceptive devices (IUCD).
    Dasgupta PR; Dutta S; Banerjee P; Majumdar S
    Int J Fertil; 1983; 28(1):55-6. PubMed ID: 6134690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminocaproic acid and menstrual loss in women using intrauterine devices.
    Kasonde JM; Bonnar J
    Br Med J; 1975 Oct; 4(5987):17-9. PubMed ID: 1174902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of meclofenamic acid on menstruation in hypermenorrheic women using intrauterine devices].
    Pizarro E; Mehech G; Hidalgo M; Muñoz G; Romero C
    Rev Chil Obstet Ginecol; 1988; 53(1):43-56. PubMed ID: 3079306
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection.
    Rauramo I; Elo I; Istre O
    Obstet Gynecol; 2004 Dec; 104(6):1314-21. PubMed ID: 15572496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.